Recall one batch of MYCOSAT 100,000IU\ML ORAL suspension
2024-02-28
الاسم التجاري الاسم العلمي رقم التسجيل رقم التشغيلة المتأثرة الشركة الصانعة Trade Name Scientific Name Register Number Affected batch number Manufacturer MYCOSAT 100,000IU\ML ORAL SUSP Nystatin 20-290-03 OB59 7 Amman Pharmaceutical Industries (API)
<p><span><span><span>Saudi FDA issued Recall one batch of</span> <span>MYCOSAT 100,000IU\ML ORAL SUSP due to </span><span lang="EN">presence</span><span> of black particles. Amman Pharmaceutical Industries (API) is voluntarily recalling the affected batch.</span></span></span></p>
<p><span><span><strong><span>For healthcare professionals, </span></strong><span>Stop dispensing the above batch immediately. Embargo/Quarantine all remaining stock. Affected batch should be returned to the supplier.</span></span></span></p>
<p><span><span><strong><span>for patients </span></strong></span></span></p>
<ul>
<li><span><span><span><span>Consult your healthcare provider prior to discontinuing use of the affected batch, or for any health concerns.</span></span></span></span></li>
<li><span><span><span><span>Contact the recalling firm or Saudi FDA if you have any questions about the recall.</span></span></span></span></li>
<li><span><span><span><span>Adverse reactions or quality problems experienced with the use of this product may be reported to </span><a href="https://ade.sfda.gov.sa/"><span>Saudi Vigilance</span></a><span> either online or call center (Call 19999).</span></span></span></span></li>
</ul>
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.